Metagenomic Next-Generation Sequencing for the Diagnosis of Fracture-related Infection
METADIAG 2
Contribution of Metagenomic Sequencing Using Nanopore Technology to the Management of Post-traumatic Bone and Joint Infections
1 other identifier
observational
100
1 country
2
Brief Summary
The value of next-generation sequencing (NGS) using Nanopore technology has been demonstrated in the case of diabetic patients' wounds or in prosthetic joint infections. The aim of this study is to demonstrate its relevance as a new diagnostic approach for fracture-related infections (FRI). Bone samples from patient with FRI will be submitted to shotgun metagenomic Next-generation sequencing using Oxford Nanopore Technology (ONT) in order to establish its diagnostic value in this context in comparison with the reference method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2024
CompletedFirst Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 5, 2025
November 1, 2025
1.8 years
November 20, 2025
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concordance between the microbiological documentation obtained by sequencing and that of the reference technique (culture)
Metagenomic sequencing will be used to determine the microbiome of fracture-related infections. Data will be compared with those of reference microbiological identification techniques (culture).
1 month
Secondary Outcomes (3)
Time to obtain final microbiological results by sequencing compared with the reference technique (culture)
1 month
Number of cases in which an adjustment of targeted antibiotic therapy would be made based on NGS results.
1 month
Microbial abundance defined by the number of reads (sequence reads) obtained per phylotype
1 month
Study Arms (1)
Fracture-related infection
Patients suspected of having acute or chronic post-traumatic osteoarticular infection according to the criteria of the FRI (Fracture-Related Infection) consensus group and scheduled to undergo a bone and/or soft tissue biopsy as part of routine care
Interventions
Samples shall be submitted to high throughput sequencing using both illumine MiSeq and Oxford Nanopore Technologies.
Eligibility Criteria
Patients admitted to hospital following trauma for whom a fracture-related infection was diagnosed.
You may qualify if:
- Age ≥ 18 years
- Diagnosis of fracture-related infection (FRI consensus group)
- Patient scheduled to undergo a bone and/or soft-tissue biopsy as part of routine care
You may not qualify if:
- Patient opposition
- Patient under a legal protection measure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
IHU, service des maladies infectieuses chroniques
Marseille, Bouches-du-Rhône, 13005, France
Military Teaching Hospital Sainte Anne
Toulon, VAR, 83000, France
Related Publications (5)
Tarabichi M, Shohat N, Goswami K, Alvand A, Silibovsky R, Belden K, Parvizi J. Diagnosis of Periprosthetic Joint Infection: The Potential of Next-Generation Sequencing. J Bone Joint Surg Am. 2018 Jan 17;100(2):147-154. doi: 10.2106/JBJS.17.00434.
PMID: 29342065RESULTGoswami K, Shope AJ, Tokarev V, Wright JR, Unverdorben LV, Ly T, Chen See J, McLimans CJ, Wong HT, Lock L, Clarkson S, Parvizi J, Lamendella R. Comparative meta-omics for identifying pathogens associated with prosthetic joint infection. Sci Rep. 2021 Dec 9;11(1):23749. doi: 10.1038/s41598-021-02505-7.
PMID: 34887434RESULTSanderson ND, Street TL, Foster D, Swann J, Atkins BL, Brent AJ, McNally MA, Oakley S, Taylor A, Peto TEA, Crook DW, Eyre DW. Real-time analysis of nanopore-based metagenomic sequencing from infected orthopaedic devices. BMC Genomics. 2018 Sep 27;19(1):714. doi: 10.1186/s12864-018-5094-y.
PMID: 30261842RESULTIvy MI, Thoendel MJ, Jeraldo PR, Greenwood-Quaintance KE, Hanssen AD, Abdel MP, Chia N, Yao JZ, Tande AJ, Mandrekar JN, Patel R. Direct Detection and Identification of Prosthetic Joint Infection Pathogens in Synovial Fluid by Metagenomic Shotgun Sequencing. J Clin Microbiol. 2018 Aug 27;56(9):e00402-18. doi: 10.1128/JCM.00402-18. Print 2018 Sep.
PMID: 29848568RESULTWalter N, Orbenes N, Rupp M, Alt V. The State of Research in Fracture-Related Infection-A Bibliometric Analysis. Medicina (Kaunas). 2022 Aug 29;58(9):1170. doi: 10.3390/medicina58091170.
PMID: 36143847RESULT
Biospecimen
tissue samples
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
LACÔTE-DELARBRE David, MD
Military Teaching Hospital Sainte Anne
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 1, 2025
Study Start
March 11, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
December 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share